about
Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV TransmissionMR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound.A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.Sulfobutyl ether(7) β-cyclodextrin (SBE(7) β-CD) carbamazepine complex: preparation, characterization, molecular modeling, and evaluation of in vivo anti-epileptic activity.Design and evaluation of microemulsions for improved parenteral delivery of propofol.Development and validation of a simple and isocratic reversed-phase HPLC method for the determination of rilpivirine from tablets, nanoparticles and HeLa cell lysates.Nanosuspensions: a promising drug delivery strategy.Development and evaluation of a thermosensitive vaginal gel containing raltegravir+efavirenz loaded nanoparticles for HIV prophylaxis.Polymeric nanoparticles containing combination antiretroviral drugs for HIV type 1 treatmentTopical Tenofovir Disoproxil Fumarate Nanoparticles Prevent HIV-1 Vaginal Transmission in a Humanized Mouse ModelParenteral microemulsions: an overview.Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances.Natural polyphenols: potential in the prevention of sexually transmitted viral infections.Preclinical Evaluation of Intravesical Cisplatin Nanoparticles for Non-Muscle-Invasive Bladder Cancer.Lecithin-based novel cationic nanocarriers (LeciPlex) I: fabrication, characterization and evaluation.Tween 80-sodium deoxycholate mixed micelles: structural characterization and application in doxorubicin delivery.Cationic nanoemulsions as potential carriers for intracellular delivery.Lecithin-based novel cationic nanocarriers (Leciplex) II: improving therapeutic efficacy of quercetin on oral administration.Characterization of soy polysaccharide and its in vitro and in vivo evaluation for application in colon drug delivery.Potential of cyclodextrin complexation and liposomes in topical delivery of ketorolac: in vitro and in vivo evaluation.Local enema treatment to inhibit FOLH1/GCPII as a novel therapy for inflammatory bowel disease.Correction: Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission.Novel delivery systems of atorvastatin should be evaluated for pharmacodynamics instead of pharmacokinetics.Hypo-osmolar Formulation of Tenofovir (TFV) Enema Promotes Uptake and Metabolism of TFV in Tissues, Leading to Prevention of SHIV/SIV Infection.Celecoxib nanosuspension: single-step fabrication using a modified nanoprecipitation method and in vivo evaluationLipid nanocarriers (GeluPearl) containing amphiphilic lipid Gelucire 50/13 as a novel stabilizer: fabrication, characterization and evaluation for oral drug deliveryDesign and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil☆Solid lipid nanoparticles (SLN) of tretinoin: Potential in topical deliveryExploring the potential of N-methyl pyrrolidone as a cosurfactant in the microemulsion systemsDevelopment and evaluation of taste masked dry syrup formulation of potassium chlorideDevelopment of rectal enema as microbicide (DREAM): Preclinical progressive selection of a tenofovir prodrug enemaDevelopment of a mucoinert progesterone nanosuspension for safer and more effective prevention of preterm birthMucus-penetrating budesonide nanosuspension enema for local treatment of inflammatory bowel disease
P50
Q27318354-2A89FB2C-4925-4C8F-B12C-18FBF8ACC11EQ30252977-C3856636-53F4-48FD-BE7E-FA34D558CAECQ30431343-3D95F50C-7437-4881-93DD-8956DEB63C63Q34019895-501B9B31-6691-45FA-9171-C7DADD676A6DQ34293452-B4E1AF57-19DA-4057-BF1C-9392FDEFBF73Q35314702-D6095C0C-7409-457F-9DCF-A5444A3983DEQ35826447-C08E7E05-E5E1-40BC-9C52-49FEE046993CQ36442232-93EDDD52-4AD0-4C1A-A004-F01D87B7C2FAQ36795898-AE899A1E-26B2-42E3-B55B-2617CFD3D016Q36933427-8296993F-E1FB-4D5B-87AD-613777868007Q37093106-B243A817-D306-471E-9686-E1045F93B69EQ37818332-B8D45553-918B-40CA-9D3D-31C9DBEE80BCQ38627591-20A5A869-A1FC-4FEE-9A74-51C1EEB42CE0Q38694932-21A9B23A-4005-4CC4-97F1-654442FD50F2Q39453040-C438C2E5-D72A-4C84-A0E8-8D1B95BEE3D3Q39631269-4451BCA4-55B0-4DE3-B5E1-A04CC2D335D4Q40314297-EE6EDAF3-BC82-4E66-BB29-8E939F3D6542Q41615986-AA149DE8-B68C-4FFE-AF9B-DB11A22F2BEEQ41988242-CDACC4C0-1437-4726-829B-97A1402EF900Q41989429-DB0876C9-AC51-47BF-A903-049FAFB4CC97Q42602745-484F0E5D-BC0C-4D33-B7E5-3ED7CE13DDAAQ43216237-8D271571-4F72-481E-B3BA-6FCBF468C9B1Q46919776-6D10DE31-4930-4557-8883-CDB2F2B159B2Q47398084-0A81B7BB-2FFD-4D76-9D7A-A0CAFFC4CF84Q58624617-68965342-18A7-4B04-97E3-FDC267441443Q58624655-93AF19B6-9B9D-4A85-9120-ED29F51AD56CQ58624688-D6449D7E-853E-41CD-B4F5-6770FE181F58Q58624711-1AD56EB8-36C1-4807-80D7-37CF6A0DCDCFQ58624717-9821AF78-CFE1-4CBA-BB92-5CDF38DAA78CQ64268329-7BD9B53F-5B90-409B-88EA-026A586183C2Q88869972-63A23FD2-5EAE-4226-AAAA-C61CDE590D89Q90825692-6543DE56-B2E6-491D-9B24-9561413365F2Q91592802-AD3FB8A1-3EC8-4162-B09C-6530887B15A1
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Abhijit A Date
@nl
Abhijit A Date
@sl
Abhijit A. Date
@en
Abhijit A. Date
@es
type
label
Abhijit A Date
@nl
Abhijit A Date
@sl
Abhijit A. Date
@en
Abhijit A. Date
@es
prefLabel
Abhijit A Date
@nl
Abhijit A Date
@sl
Abhijit A. Date
@en
Abhijit A. Date
@es
P106
P1153
8762971800
P21
P31
P496
0000-0001-6617-882X